191 related articles for article (PubMed ID: 18395430)
1. Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Vauthier C; Chacun H; Ponchel G
Eur J Pharm Biopharm; 2008 Jun; 69(2):436-44. PubMed ID: 18395430
[TBL] [Abstract][Full Text] [Related]
2. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Vauthier C; Farabollini A; Palmieri GF; Ponchel G
Biomaterials; 2007 Apr; 28(13):2233-43. PubMed ID: 17261330
[TBL] [Abstract][Full Text] [Related]
3. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
4. Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles.
Bravo-Osuna I; Ponchel G; Vauthier C
Eur J Pharm Sci; 2007 Feb; 30(2):143-54. PubMed ID: 17157487
[TBL] [Abstract][Full Text] [Related]
5. Intestinal permeation enhancement of docetaxel encapsulated into methyl-β-cyclodextrin/poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan.
Mazzaferro S; Bouchemal K; Skanji R; Gueutin C; Chacun H; Ponchel G
J Control Release; 2012 Sep; 162(3):568-74. PubMed ID: 22902592
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of calcium binding capacity of chitosan and thiolated chitosan poly(isobutyl cyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Millotti G; Vauthier C; Ponchel G
Int J Pharm; 2007 Jun; 338(1-2):284-90. PubMed ID: 17367968
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
8. Preparation of nanoparticles composed of chitosan/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells.
Lin YH; Chung CK; Chen CT; Liang HF; Chen SC; Sung HW
Biomacromolecules; 2005; 6(2):1104-12. PubMed ID: 15762683
[TBL] [Abstract][Full Text] [Related]
9. Mucoadhesive properties of low molecular weight chitosan- or glycol chitosan- and corresponding thiomer-coated poly(isobutylcyanoacrylate) core-shell nanoparticles.
Palazzo C; Trapani G; Ponchel G; Trapani A; Vauthier C
Eur J Pharm Biopharm; 2017 Aug; 117():315-323. PubMed ID: 28455206
[TBL] [Abstract][Full Text] [Related]
10. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
[TBL] [Abstract][Full Text] [Related]
11. Cell line-dependent cytotoxicity of poly(isobutylcyanoacrylate) nanoparticles coated with chitosan and thiolated chitosan: Insights from cultured human epithelial HeLa, Caco2/TC7 and HT-29/MTX cells.
Pradines B; Lievin-Le Moal V; Vauthier C; Ponchel G; Loiseau PM; Bouchemal K
Int J Pharm; 2015 Aug; 491(1-2):17-20. PubMed ID: 26051544
[TBL] [Abstract][Full Text] [Related]
12. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
13. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles.
Bravo-Osuna I; Schmitz T; Bernkop-Schnürch A; Vauthier C; Ponchel G
Int J Pharm; 2006 Jun; 316(1-2):170-5. PubMed ID: 16580797
[TBL] [Abstract][Full Text] [Related]
14. Improved synthesis of quaternary ammonium-chitosan conjugates (N+ -Ch) for enhanced intestinal drug permeation.
Zambito Y; Zaino C; Uccello-Barretta G; Balzano F; Di Colo G
Eur J Pharm Sci; 2008 Apr; 33(4-5):343-50. PubMed ID: 18296036
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
16. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
17. Characterization of chitosan thiolation and application to thiol quantification onto nanoparticle surface.
Bravo-Osuna I; Teutonico D; Arpicco S; Vauthier C; Ponchel G
Int J Pharm; 2007 Aug; 340(1-2):173-81. PubMed ID: 17592748
[TBL] [Abstract][Full Text] [Related]
18. Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel.
Agüeros M; Ruiz-Gatón L; Vauthier C; Bouchemal K; Espuelas S; Ponchel G; Irache JM
Eur J Pharm Sci; 2009 Nov; 38(4):405-13. PubMed ID: 19765652
[TBL] [Abstract][Full Text] [Related]
19. Novel composite core-shell nanoparticles as busulfan carriers.
Layre A; Couvreur P; Chacun H; Richard J; Passirani C; Requier D; Benoit JP; Gref R
J Control Release; 2006 Apr; 111(3):271-80. PubMed ID: 16488504
[TBL] [Abstract][Full Text] [Related]
20. Characterization of fluorescent poly(isobutylcyanoacrylate) nanoparticles obtained by copolymerization of a fluorescent probe during Redox Radical Emulsion Polymerization (RREP).
Zandanel C; Vauthier C
Eur J Pharm Biopharm; 2012 Sep; 82(1):66-75. PubMed ID: 22634238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
